STERIS (STE)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for STE
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| STE | CEO of bioMérieux; Chief Executive Officer | 54 | ["Chief Executive Officer of a European-based biotechnology company","many years of industry experience","extensive leadership experience","global perspective","operational expertise"] | [] | 2026 |
Biography sourced from the proxy statement filing.
Mr. Boulud is the Chief Executive Officer of bioM rieux, a biotechnology company focused on in vitro diagnostics, cancer screening and consumer safety, having served in that role since June 2023. Mr. Boulud joined bioM rieux in 2016 as Corporate Vice President, Head of Asia Pacific Region, and was promoted to Chief Operating Officer in 2020. Previously, he worked at Ipsen, a pharmaceutical company, from 2002 until 2016, serving in various roles of increasing responsibility and ultimately as the Executive Vice President of Specialty Care Commercial Operations. Mr. Boulud began his career as a strategic consultant, working at Bossard Consultants from 1995 to 1997 and at the Boston Consulting Group from 1997 to 2002. Qualifications. Mr. Boulud s role as a Chief Executive Officer of a European-based biotechnology company and many years of industry experience. He brings extensive leadership experience, global perspective, and operational expertise to the Board. Chief Executive Officer of bioM rieux Director since: 2026 Age: 54 Committees: None